Dr. Guru Prasad Manderwad, is a medical microbiologist and scientist. His research is mainly focused on the epigenetic mode of bacterial drug resistance. He has been awarded doctorate degree from the reputed Institute BITS, Pilani. He has received research grants from Govt of India for the projects aiming to evaluate the presence of methyltransferase enzymes and its role in the emergence of bacterial drug resistance. Previously he has received “Young Investigation award” from DST, Govt. of India. He is forefront in doing research in the field of infectious diseases and has been awarded research grant for evaluating the polymorphism of Interferon gamma and susceptibility to pulmonary tuberculosis. He also found a potential epigenetic biomarker for ocular squamous cell carcinoma. He has done extensive research work on the ocular squamous cell carcinoma.
Dr. Guru Prasad has published 40 papers in in prestigious peer review national and International journals. He is serving editorial board member of reputed journal including British Biomedical Bulletin, Journal of genetic disorders.
Awards:
- Outstanding Researcher Award- Interdisciplinary Research for sustainable development Greenthinkerz.org-Chandigarh, India-2019
- Best Researcher Award- International Organization of Scientific Research and Development- New Delhi- April 2019.
- Foxclues India Prime Top 100 researchers award-2022
- IJMTST Excellence research awards-2022
- Selected for – Best Researcher Award from Pencis International Research Awards on Infectious Diseases -2022